J17 Capital, a North American-focused investment firm, fuels growth in tech, pharma, and therapy sectors.
Location
Toronto, Ontario, CA
Founded
2020
J17 Capital is a North American venture capital firm focusing on technology, pharmaceutical, and therapeutic industries. The firm specializes in growth equity investments, targeting middle market to late-stage entities. J17 Capital's investment strategy spans from Series A to Series C rounds, demonstrating flexibility in supporting companies at various growth stages.
The firm's portfolio includes notable companies such as Medallion, a music industry platform, and Osaro, a leader in AI-powered robotics. J17 Capital's team brings years of experience across multiple fields, contributing to their strong track record of successful investments. They emphasize partnering with portfolio companies, leveraging their expertise to drive growth and pave the way for a better future.
J17 Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Series A1 (33.3%)
Series C1 (33.3%)
Series D1 (33.3%)
Stage Mix
Series A 33%Series C 33%Series D 33%
Concentration shown as share of disclosed investments by stage.
